Technology News and Research

RSS

Asuragen reports collaborative study results of advanced PCR-based molecular profiling of FMR1 gene

Asuragen, Inc. announced today the results from two collaborative studies, one with the University of California Davis M.I.N.D. Institute and another with Rush University Medical Center, that demonstrate comprehensive molecular profiling of the Fragile X Mental Retardation (FMR1) gene using advanced PCR-based methods.

26 Jul 2010

Nano-patch to replace needles for vaccination soon: Study

Those who fear needles have good news awaiting them. Australian researchers have developed a new method of vaccine delivery using needle-free nano-patches. These could also be mailed to people during pandemics. This breakthrough is published in the latest edition of the journal Small.

26 Jul 2010

UnitedHealth ups ante on health IT with purchase of Picis, expecting stimulus windfall

Minneapolis-St. Paul Business Journal: UnitedHealth Group's technology consulting subsidiary Ingenix, of Eden Prairie, Minn., has purchased Massachusetts tech firm Picis, a maker of emergency room and intensive care software. "Both companies are deeply involved in the area where health care and information technology meet. Ingenix, which had revenue of $1.8 billion last year, provides consulting and outsourcing to almost 6,000 hospitals.

26 Jul 2010

Sartorius reports substantial gain in first half for 2010

Today Sartorius, a leading international process and laboratory technology provider, published its first-half results for 2010. Both the Biotechnology Division and the Mechatronics Division reported substantial gains in order intake and sales revenue. The two divisions expanded their business in all regions. Besides the continued strong development in the Biotechnology Division, the positive earnings contributed by the Mechatronics Division are especially encouraging, given that this division faced an exceptionally adverse business climate last year as a result of the global economic crisis.

From Sartorius 26 Jul 2010

North Shore-LIJ Health System seeks oropharynx patients for phase I clinical trial

The North Shore-LIJ Health System Department of Radiation Medicine announced today it is seeking patients with cancer of the oropharynx (back of the mouth) to participate in a Phase I clinical trial.Subjects must be newly diagnosed and not have undergone any previous treatment. Further, their cancer must be unassociated with the human papilloma virus (HPV-negative), or, if it is HPV-positive, they must be current or former pack-a-day smokers for at least 10 years.

26 Jul 2010

MedNet announces significant improvements to EMPOWER system

MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, is pleased to announce significant enhancements to EMPOWER, the company's comprehensive investigator initiated - sponsored research management solution. The EMPOWER system is currently being utilized on a world-wide basis by numerous pharmaceutical and medical device companies to automate and streamline investigator research submissions, management and reporting.

26 Jul 2010

FDA grants marketing approval of ANDA for enoxaparin sodium for injection

Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that the U.S. Food and Drug Administration has granted marketing approval of the Abbreviated New Drug Application for enoxaparin sodium for injection filed by Sandoz. Developed under a collaboration agreement between Momenta and Sandoz, this product has been designated therapeutically equivalent to the reference-listed drug, Lovenox, which is marketed by Sanofi-Aventis.

26 Jul 2010

Cancer institute offers new tumor monitoring system for radiation therapy patients

A new system that utilizes a precise a GPS-like system to track prostate cancer tumors is now being offered to patients undergoing radiation therapy at Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute. The monitoring system, called Calypso, allows radiation beams to more precisely target the cancer as it gives real-time positioning information that allows the radiation beams to focus directly on the cancer.

23 Jul 2010

Most Americans with disabilities still struggle with lifestyle, economic issues: Survey

On the 20th anniversary of the signing of the Americans with Disabilities Act, a new survey sponsored by Kessler Foundation and National Organization on Disability finds that most Americans with disabilities are still struggling with many of the same lifestyle and economic issues they confronted in 1990 when the ADA became federal law.

23 Jul 2010

Update on Phase III Study of oral calcitonin for treatment of osteoarthritis

Emisphere Technologies, Inc. today announced that Novartis Pharma AG and its license partner Nordic Bioscience a/s have reported the following in connection with their Phase III Study 2302 in osteoarthritis assessing the safety and efficacy of oral calcitonin in the treatment of osteoarthritis of the knee.

23 Jul 2010

Novartis, Nordic Bioscience to continue oral calcitonin Phase III study in osteoarthritis patients

Unigene Laboratories, Inc. announced today that Novartis and its license partner Nordic Bioscience have decided to continue the companies' two-year, Phase III Study 2302 assessing safety and efficacy of oral calcitonin in patients with osteoarthritis of the knee. Novartis has a worldwide license to produce recombinant calcitonin under Unigene's patented SecraPep® E. coli manufacturing technology.

23 Jul 2010

IDEXX Laboratories second-quarter 2010 revenues increase 6% to $281.5 million

IDEXX Laboratories, Inc., today reported that revenues for the second quarter of 2010 increased 6% to $281.5 million, from $265.7 million for the second quarter of 2009. Organic revenue growth, as defined below, was 5%. Earnings per diluted share for the quarter ended June 30, 2010 increased 13% to $0.62, compared to $0.55 for the same period in the prior year.

23 Jul 2010

MiMedx Group reports revenues of $322,000 for second-quarter 2010

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today its results for the second quarter ended June 30, 2010.

23 Jul 2010

Maven Semantic announces updates to Bioinformatics medical professionals database

Maven Semantic announces updates to their Bioinformatics database.

23 Jul 2010

Businesses prepare for health IT push; AMA worries small practices might struggle

In expectation of expansive new federal spending on electronic medical records, technology firms are expanding their health care businesses, Politico reports. "Now that the Obama administration has finalized the rules by which health care providers can be reimbursed for the systems with billions in stimulus dollars, they're making serious plans to transition from paper to digital records — an expensive process that information technology and telecom companies are eager to help with."

23 Jul 2010

Kaiser Permanente's Total Joint Replacement Registry enhances patient safety, quality of care

A total joint replacement registry based on carefully designed and integrated technology can enhance patient safety, quality of care, cost-effectiveness and research, according to a paper published in the online and print editions of Clinical Orthopedics and Related Research, a journal of the Association of Bone and Joint Surgeons.

23 Jul 2010

ISCO to create new European subsidiary with $10 million capital funding

International Stem Cell Corporation, announced today that it had entered into a Memorandum of Understanding with ARG Vermogensverwaltung AG, a German Investment Fund, to create a new European subsidiary ("ISCO Europe") to be funded with up to $10 million of capital derived from ARG and other independent sources in Europe. Shares of ISCO Europe are expected to trade on the Deutsche Bourse independently of the company's shares in the US. ISCO Europe's shares will not be convertible into ISCO shares on any US exchange.

23 Jul 2010

Technology News and Research

Asuragen reports collaborative study results of advanced PCR-based molecular profiling of FMR1 gene

Nano-patch to replace needles for vaccination soon: Study

UnitedHealth ups ante on health IT with purchase of Picis, expecting stimulus windfall

Sartorius reports substantial gain in first half for 2010

North Shore-LIJ Health System seeks oropharynx patients for phase I clinical trial

MedNet announces significant improvements to EMPOWER system

FDA grants marketing approval of ANDA for enoxaparin sodium for injection

Cancer institute offers new tumor monitoring system for radiation therapy patients

Most Americans with disabilities still struggle with lifestyle, economic issues: Survey

Update on Phase III Study of oral calcitonin for treatment of osteoarthritis

Novartis, Nordic Bioscience to continue oral calcitonin Phase III study in osteoarthritis patients

IDEXX Laboratories second-quarter 2010 revenues increase 6% to $281.5 million

MiMedx Group reports revenues of $322,000 for second-quarter 2010

Maven Semantic announces updates to Bioinformatics medical professionals database

Businesses prepare for health IT push; AMA worries small practices might struggle

Kaiser Permanente's Total Joint Replacement Registry enhances patient safety, quality of care

ISCO to create new European subsidiary with $10 million capital funding

Teleflex second-quarter net revenues increase 5% to $461.7 million

Funding for new medical ventures improving

Researchers share nanotechnology knowledge

Industry Focus eBook - Cell biology (5th edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News